Anthi Maslarinou 个人学术档案 - 学术资源搜索

引用次数

	总计	2019 年至今
引用	19	19
h 指数	3	3
i10 指数	1	1

0

14

7

202320246 13

合著作者

Vangelis ManolopoulosProfessor of Pharmacology, Pharmacogenomics, and Precision Medicine, Democritus University of Thrace在 med.duth.gr 的电子邮件经过验证
Natalia AtzemianPhD Student, University of Zurich在 uzh.ch 的电子邮件经过验证

Anthi Maslarinou

Anthi Maslarinou

Researcher, Democritus University of Thrace

在 med.duth.gr 的电子邮件经过验证 - 首页

Pharmacogenomics Epigenomics Cardiovascular Pharmacology Cancer Pharmacogenomics


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm? A Maslarinou, VG Manolopoulos, G Ragia Frontiers in Pharmacology 14, 1184523, 2023	11	2023
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece G Ragia, A Maslarinou, N Atzemian, E Biziota, T Koukaki, C Ioannou, ... Frontiers in Pharmacology 14, 1248898, 0	5
SLCO1B1 c. 521T> C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients G Ragia, N Atzemian, A Maslarinou, VG Manolopoulos Drug Metabolism and Personalized Therapy 37 (4), 347-352, 2022	3	2022
Effect of therapy with direct oral anticoagulants on PITX2 gene methylation in atrial fibrillation patients A Maslarinou, G Ragia, T Thomopoulos, N Dovrolis, G Kolios, A Trikas, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S40-S40, 2022		2022

系统目前无法执行此操作，请稍后再试。

文章 1–4